Toolkit/recombinase polymerase amplification
recombinase polymerase amplification
Also known as: RPA
Taxonomy: Technique Branch / Method. Workflows sit above the mechanism and technique branches rather than replacing them.
Summary
Recombinase polymerase amplification (RPA) is used in the cited study as an amplification component within a combined diagnostic workflow that also includes photoactivated CRISPR-Cas12a and a tube-in-tube structure for visual detection of HPV16. The supplied evidence supports its inclusion in this integrated assay, but does not provide mechanistic detail about RPA itself.
Usefulness & Problems
Why this is useful
In the cited work, RPA is useful as part of a combined system for visual HPV16 detection. The study further presents the overall platform as a potential on-site diagnostic tool with possible portability and speed benefits.
Source:
to enable simple, rapid and convenient visualization detection of HPV16, facilitated by blue UV light at 302 nm
Problem solved
The evidence indicates that RPA contributes to an integrated assay designed to detect HPV16 visually. The specific problem addressed is incorporation of nucleic acid amplification into a light-triggered CRISPR-Cas12a diagnostic workflow.
Source:
to enable simple, rapid and convenient visualization detection of HPV16, facilitated by blue UV light at 302 nm
Problem links
RPA is included here as part of a nucleic-acid detection workflow, so it plausibly helps with rapid pathogen detection. As an amplification method, it could improve sensitivity for early detection when pathogen loads are low.
Taxonomy & Function
Primary hierarchy
Technique Branch
Method: A concrete method used to build, optimize, or evolve an engineered system.
Mechanisms
No mechanism tags yet.
Techniques
No technique tags yet.
Target processes
diagnosticeditingrecombinationInput: Light
Implementation Constraints
The cited implementation places RPA in a workflow combined with photoactivated CRISPR-Cas12a and a tube-in-tube structure for HPV16 detection. The overall assay is associated with visual readout facilitated by 302 nm blue UV light, but the evidence does not specify RPA construct design, enzymes, primers, or reaction setup.
The supplied evidence does not describe RPA's molecular mechanism, target sequence requirements, reaction conditions, sensitivity, specificity, or standalone performance. Validation is limited here to its use as one component of a single combined HPV16 diagnostic application.
Validation
Supporting Sources
Ranked Claims
The combined system enables visual detection of HPV16 facilitated by blue UV light at 302 nm.
to enable simple, rapid and convenient visualization detection of HPV16, facilitated by blue UV light at 302 nm
The combined system enables visual detection of HPV16 facilitated by blue UV light at 302 nm.
to enable simple, rapid and convenient visualization detection of HPV16, facilitated by blue UV light at 302 nm
The combined system enables visual detection of HPV16 facilitated by blue UV light at 302 nm.
to enable simple, rapid and convenient visualization detection of HPV16, facilitated by blue UV light at 302 nm
The combined system enables visual detection of HPV16 facilitated by blue UV light at 302 nm.
to enable simple, rapid and convenient visualization detection of HPV16, facilitated by blue UV light at 302 nm
The combined system enables visual detection of HPV16 facilitated by blue UV light at 302 nm.
to enable simple, rapid and convenient visualization detection of HPV16, facilitated by blue UV light at 302 nm
The combined system enables visual detection of HPV16 facilitated by blue UV light at 302 nm.
to enable simple, rapid and convenient visualization detection of HPV16, facilitated by blue UV light at 302 nm
The study combines photoactivated CRISPR-Cas12a, a tube-in-tube structure, and recombinase polymerase amplification for visual detection of HPV16.
we have combined photoactivated CRISPR-Cas12a with tube-in-tube structure and recombinase polymerase amplification (RPA) to enable simple, rapid and convenient visualization detection of HPV16
The study combines photoactivated CRISPR-Cas12a, a tube-in-tube structure, and recombinase polymerase amplification for visual detection of HPV16.
we have combined photoactivated CRISPR-Cas12a with tube-in-tube structure and recombinase polymerase amplification (RPA) to enable simple, rapid and convenient visualization detection of HPV16
The study combines photoactivated CRISPR-Cas12a, a tube-in-tube structure, and recombinase polymerase amplification for visual detection of HPV16.
we have combined photoactivated CRISPR-Cas12a with tube-in-tube structure and recombinase polymerase amplification (RPA) to enable simple, rapid and convenient visualization detection of HPV16
The study combines photoactivated CRISPR-Cas12a, a tube-in-tube structure, and recombinase polymerase amplification for visual detection of HPV16.
we have combined photoactivated CRISPR-Cas12a with tube-in-tube structure and recombinase polymerase amplification (RPA) to enable simple, rapid and convenient visualization detection of HPV16
The study combines photoactivated CRISPR-Cas12a, a tube-in-tube structure, and recombinase polymerase amplification for visual detection of HPV16.
we have combined photoactivated CRISPR-Cas12a with tube-in-tube structure and recombinase polymerase amplification (RPA) to enable simple, rapid and convenient visualization detection of HPV16
The study combines photoactivated CRISPR-Cas12a, a tube-in-tube structure, and recombinase polymerase amplification for visual detection of HPV16.
we have combined photoactivated CRISPR-Cas12a with tube-in-tube structure and recombinase polymerase amplification (RPA) to enable simple, rapid and convenient visualization detection of HPV16
The system is presented as a potential tool for on-site diagnostic use with possible portability and speed benefits.
It serves as a potential tool for on-site diagnostic use, which could be beneficial in terms of portability and speed.
The system is presented as a potential tool for on-site diagnostic use with possible portability and speed benefits.
It serves as a potential tool for on-site diagnostic use, which could be beneficial in terms of portability and speed.
The system is presented as a potential tool for on-site diagnostic use with possible portability and speed benefits.
It serves as a potential tool for on-site diagnostic use, which could be beneficial in terms of portability and speed.
The system is presented as a potential tool for on-site diagnostic use with possible portability and speed benefits.
It serves as a potential tool for on-site diagnostic use, which could be beneficial in terms of portability and speed.
The system is presented as a potential tool for on-site diagnostic use with possible portability and speed benefits.
It serves as a potential tool for on-site diagnostic use, which could be beneficial in terms of portability and speed.
The system is presented as a potential tool for on-site diagnostic use with possible portability and speed benefits.
It serves as a potential tool for on-site diagnostic use, which could be beneficial in terms of portability and speed.
Approval Evidence
combined photoactivated CRISPR-Cas12a with tube-in-tube structure and recombinase polymerase amplification (RPA)
Source:
The combined system enables visual detection of HPV16 facilitated by blue UV light at 302 nm.
to enable simple, rapid and convenient visualization detection of HPV16, facilitated by blue UV light at 302 nm
Source:
The study combines photoactivated CRISPR-Cas12a, a tube-in-tube structure, and recombinase polymerase amplification for visual detection of HPV16.
we have combined photoactivated CRISPR-Cas12a with tube-in-tube structure and recombinase polymerase amplification (RPA) to enable simple, rapid and convenient visualization detection of HPV16
Source:
The system is presented as a potential tool for on-site diagnostic use with possible portability and speed benefits.
It serves as a potential tool for on-site diagnostic use, which could be beneficial in terms of portability and speed.
Source:
Comparisons
Source-backed strengths
The main supported strength is compatibility with photoactivated CRISPR-Cas12a and a tube-in-tube assay format in a visual HPV16 detection system. The overall combined system is reported to enable visual detection facilitated by blue UV light at 302 nm and is proposed for potential on-site use.
Compared with multiplexed engineering
recombinase polymerase amplification and multiplexed engineering address a similar problem space because they share editing, recombination.
Shared frame: same top-level item type; shared target processes: editing, recombination
Relative tradeoffs: looks easier to implement in practice.
Compared with photoactivatable CRISPR/Cas12a system
recombinase polymerase amplification and photoactivatable CRISPR/Cas12a system address a similar problem space because they share diagnostic, editing, recombination.
Shared frame: shared target processes: diagnostic, editing, recombination; same primary input modality: light
Relative tradeoffs: appears more independently replicated.
Compared with tube-in-tube structure
recombinase polymerase amplification and tube-in-tube structure address a similar problem space because they share diagnostic, editing, recombination.
Shared frame: shared target processes: diagnostic, editing, recombination; same primary input modality: light
Ranked Citations
- 1.